Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism
Authors:
- 27 March 2010
- journal article
- Published by Elsevier in Behavioural Brain Research
- Vol. 211 (2) , 236-239
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson modelBrain Research, 2009
- Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New DataJournal of Child and Adolescent Psychopharmacology, 2007
- Synthesizing Schizophrenia: A Bottom-Up, Symptomatic ApproachSchizophrenia Bulletin, 2005
- Attention and executive function deficits in chronic low‐dose MPTP‐treated non‐human primatesEuropean Journal of Neuroscience, 2004
- Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeysBehavioural Brain Research, 2004
- Treatment with the Noradrenergic Alpha-2 Agonist Clonidine, But Not Diazepam, Improves Spatial Working Memory in Normal Young Rhesus MonkeysNeuropsychopharmacology, 1999
- Effects of the nicotinic acetylcholine receptor agonist SIB‐1508Y on object retrieval performance in MPTP‐Treated monkeys: Comparison with levodopa treatmentAnnals of Neurology, 1998
- Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeysBrain Research, 1993
- Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeysBrain Research, 1990
- ‘FRONTAL’ COGNITIVE FUNCTION IN PATIENTS WITH PARKINSON'S DISEASE ‘ON’AND ‘OFF’ LEVODOPABrain, 1988